Almac Clinical Technologies and THREAD Partner to Eliminate Common Trial Delays


Almac Clinical Technologies, a member of the contract and development organization, Almac Group, and THREAD, a technology and service provider enabling decentralized clinical trials (DCTs), have announced a strategic partnership. They will integrate their technologies aiming to enable more efficient clinical trials that generate better outcomes.

By integrating their proprietary technology platforms, Almac and THREAD will provide sponsors and contract research organizations with a full range of tools aiming to reduce the risk of trial delays. Almac’s IXRS solution and services for randomization and clinical trial supply management will be available to THREAD customers and THREAD’s DCT solution will be available to Almac customers. The two companies will leverage single sign-on and application program interfaces to integrate their technologies and automate DCT workflows across their respective platforms to:

  • minimize duplicate data entry, particularly for research sites
  • provide sponsors with integrated reports on trial progress
  • preserve automation to ensure operational efficiency

More on their partnership

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.